Bristol Graham Number from 2010 to 2026

BMY Stock  USD 55.86  0.04  0.07%   
Bristol Myers Graham Number yearly trend continues to be fairly stable with very little volatility. Graham Number is likely to outpace its year average in 2026. During the period from 2010 to 2026, Bristol Myers Graham Number regression line of annual values had r-squared of  0.67 and arithmetic mean of  24.58. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
31.71
Current Value
33.3
Quarterly Volatility
10.24797812
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.6 B, Interest Expense of 2.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0378 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Graham Number Growth Pattern

Below is the plot of the Graham Number of Bristol Myers Squibb over the last few years. It is Bristol Myers' Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Bristol Graham Number Regression Statistics

Arithmetic Mean24.58
Geometric Mean21.87
Coefficient Of Variation41.70
Mean Deviation8.81
Median24.13
Standard Deviation10.25
Sample Variance105.02
Range32.0551
R-Value0.82
Mean Square Error36.91
R-Squared0.67
Significance0.000058
Slope1.66
Total Sum of Squares1,680

Bristol Graham Number History

2026 33.3
2025 31.71
2023 35.23
2022 31.22
2020 33.86
2019 37.06
2018 24.13

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Graham Number, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 31.71  33.30 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.